Drug Trial Radar · NCT05552274
FTIH of ECC4703 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Jul 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
75
Actual
Start
Aug 16, 2022
Primary completion
Oct 26, 2023
Study completion Oct 26, 2023
Sponsor
- Lead sponsor
- EccogeneIndustry
- Sponsor type
- Industry
- First posted
- Sep 23, 2022
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase 1, randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study of ECC4703 in healthy volunteers and participants with treatment unnecessary LDL-C under 160 mg/dL
Conditions
- Non-alcoholic Steatohepatitis (NASH)
Interventions
ECC4703Drug
ECC4703 will be administered as 1 mg, 10 mg and 40 mg capsules. ECC4703 will be administered as oral capsules during each dosing day.
PlaceboDrug
Matching Placebo will be administered as oral capsules. Matching Placebo will be given orally during each dosing day.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with adverse events, with abnormal laboratory test results, abnormal ECGs, abnormal vital signs, and abnormal physical examinationsTime frame: SAD: Up to 8 days and MAD: Up to 21 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Eccogene Investigational Site
Las Vegas, Nevada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.